Koyfin Home > Directory > Health Care > Adma Biologics > Return on Assets %

Adma Biologics Return on Assets % Chart (ADMA)

Adma Biologics annual/quarterly Return on Assets % from 2011 to 2020.
  • Adma Biologics Return on Assets % for the quarter ending September 09, 2020 was -18.09 a 18.31% decrease of -3.31 year over year
  • Adma Biologics Return on Assets % for the last 12 months ending September 09, 2020 was -21.17 a -13.23% increase of 2.80 year over year
  • Adma Biologics Annual Return on Assets % for 2019 was -23.98 a -59.64% increase of 14.30 from 2018
  • Adma Biologics Annual Return on Assets % for 2018 was -38.27 a -1.58% increase of 0.60 from 2017
  • Adma Biologics Annual Return on Assets % for 2017 was -38.88 a -17.55% increase of 6.82 from 2016
Other Margins & Efficiency Metrics:
  • Adma Biologics EBITDA Margin for the quarter ending June 06, 2018 was $-270m a 24.55% decrease of -66m year over year
  • Adma Biologics Return on Capital % for the quarter ending September 09, 2018 was -40.32 a 8.20% decrease of -3.30 year over year
  • Adma Biologics Return on Equity % for the quarter ending September 09, 2018 was -136.10 a -43.11% increase of 58.67 year over year
View Chart On Koyfin

Quarterly ADMA Return on Assets % Data

09/2020-18.09
06/2020-21.29
03/2020-24.84
12/2019-14.77
09/2019-16.10
06/2019-25.61
03/2019-39.55
12/2018-42.38
09/2018-30.77
06/2018-32.12

Annual ADMA Return on Assets % Data

2019-23.98
2018-38.27
2017-38.88
2016-45.70
2015-38.22
2014-33.94
2013-39.56
2012-53.49
2011-41.33
2010-53.12